Bioasis Technologies Inc.
BIOAF
$0.00
$0.00-66.67%
OTC PK
| 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 268.33% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 268.33% | -- | -- | -- | -- |
| Cost of Revenue | -31.84% | -41.16% | -- | -16.63% | 8.44% |
| Gross Profit | 74.64% | 69.98% | -- | 16.63% | 5.14% |
| SG&A Expenses | 14.05% | -4.35% | -25.76% | -4.36% | 0.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.96% | -16.88% | -22.17% | -9.41% | 3.00% |
| Operating Income | 16.13% | 26.70% | 22.17% | 9.41% | 1.76% |
| Income Before Tax | 27.83% | -81.50% | 57.93% | 47.90% | -248.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 27.83% | -81.50% | 57.93% | 47.90% | -248.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.83% | -81.50% | 57.93% | 47.90% | -248.64% |
| EBIT | 16.13% | 26.70% | 22.17% | 9.41% | 1.76% |
| EBITDA | 18.87% | 28.43% | 22.47% | 9.76% | 1.81% |
| EPS Basic | 33.57% | -66.15% | 58.33% | 46.09% | -233.33% |
| Normalized Basic EPS | 34.09% | -61.90% | 57.89% | 37.10% | -76.00% |
| EPS Diluted | 33.57% | -66.15% | 58.33% | 46.09% | -233.33% |
| Normalized Diluted EPS | 34.09% | -61.90% | 57.89% | 37.10% | -76.00% |
| Average Basic Shares Outstanding | 8.41% | 8.41% | 1.07% | -2.86% | 11.18% |
| Average Diluted Shares Outstanding | 8.41% | 8.41% | 1.07% | -2.86% | 11.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |